Vitamin E Deficiency in Variant Angina

Circulation

Volumn 94, Issue 1, 1996, Pages 14-18

  Miwa, Kunihisa ^a   Miyagi, Yuko ^a   Igawa, Akihiko ^a   Nakagawa, Keiko ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angina; Antioxidants; Coronary disease; Lipoproteins; Vasospasm

Indexed keywords

ALPHA TOCOPHEROL; CALCIUM CHANNEL BLOCKING AGENT;

ALPHA TOCOPHEROL DEFICIENCY; ANGINA PECTORIS; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; VARIANT ANGINA PECTORIS;

ANGINA PECTORIS; ANGINA PECTORIS, VARIANT; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; VITAMIN E; VITAMIN E DEFICIENCY;

EID: 0030187047     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.1.14     Document Type: Article

References (39)

1. Maseri A, Seven S, DeNes M, L'Abbate A, Chierchia S, Marzilli M, Ballestra AM, Parodi O, Biagini A, Distante A. 'Variant' angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Am J Cardiol. 1978;42:1019-1035.
2. Yasue H, Omote S, Takizawa A, Nagao M. Coronary arterial spasm in ischemic heart disease and its pathogenesis: a review. Circ Res. 1983;52(suppl I):I-147-I-152.
3. Miwa K, Fujita M, Ejiri M, Sasayama S. Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris. Am Heart J. 1990;120:544-550.
4. Miwa K, Fujita M, Asanoi H, Sasayama S. Pathogenesis of unstable angina with 0- or 1-vessel disease: important role of coronary artery spasm. Jpn Heart J. 1992;33:739-753.
5. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein in atherogenicity. N Engl J Med. 1989;320:915-924.
6. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
7. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
8. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
9. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
10. Galle J, Bassenge E, Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res. 1990;66:1287-1293.
11. Simon BC, Cunningham LD, Cohen RA. Oxidized lipoprotein low density lipoproteins cause contraction and inhibit endothelium dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
12. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991;83:2012-2020.
13. Chin JH, Azhan S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 1992;89:10-18
14. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr. 1991;53(suppl):1050S-1055S.
15. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991;53(suppl):314S-321S.
16. Steiner M, Anastasi J. Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest. 1976;57:732-737.
17. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by alpha-tocopherol. J Biol Chem. 1991;26:6188-6194.
18. Riemersma RA, Word DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E and carotene. Lancet. 1991;1:1-5.
19. Miwa K, Miyagi Y, Fujita M. Susceptibility of plasma low-density lipoprotein to cupric ion-induced peroxidation in patients with variant angina. J Am Coll Cardiol. 1995;26:632-638.
20. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1334-1353.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
22. Thompson JN, Hatina G. Determination of tocopherols and tocotriennols in food and tissues by high-performance liquid chromatography. J Lipid Chromatogr. 1979;2:327-344.
23. Ferrari R, Ceconi C, Curello S, Gargnoni A, Condorelli E, Raddino R. Role of oxygen in myocardial ischemia and reperfusion damage: effect of tocopherol. Acta Vitaminol Enymol. 1985;7(suppl):61-70.
24. Lynch SM, Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low-density lipoprotein. J Lipid Res. 1993;34:1745-1753.
25. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991;88:1646-1650.
26. Hatam LT, Kayden HJ. The failure of α-tocopherol supplementation to alter the distribution of lipoprotein cholesterol in normal and hyperlipoproteinemic persons. Am J Clin Pathol. 1981;76:122-124.
27. Bieri TG, Evarts RP. γ-Tocopherol: metabolism, biological activity and significance in human nutrition. Am J Clin Nutr. 1974;27:980-986.
28. Peake IR, Bieri JG. Alpha- and gamma-tocopherol in the rat: in vitro and in vivo tissue uptake and metabolism. J Nutr. 1971;101:1615-1622.
29. 3H]methionine into terpenoid quinones and chromanols in maize shoots. Biochem J. 1968;06:107-112.
30. Keaney JF Jr, Gaziano JM, Xu A, Frei B, Curran-Celantano J, Shwaery GT, Loscalzo J, Vita JA. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci U S A. 1993;90:11880-11884.
31. Andersson TLG, Matz J, Ferns GAA, Änggård EE. Vitamin E reverses cholesterol-induced endothelial dysfunction in the rabbit coronary circulation. Atherosclerosis. 1994;111:39-45.
32. Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Änggård EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb. 1994;14: 494-499.
33. Croft KD, Dimmitt SB, Moulton C, Beilin LJ. Low density lipoprotein composition and oxidizability in coronary disease - apparent favourable effect of beta blockers. Atherosclerosis. 1992;97:123-130.
34. Babiy AV, Gebicki JM, Sullivan DR. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis. 1990;81:175-182.
35. Kuga T, Ohara Y, Hata H, Hirakawa Y, Tomoike H, Takeshita A. Inhibitory effects of heparin, aspirin and ketanserin on coronary artery vasoconstriction after arterial balloon injury in hypercholesterolemic miniature pigs. J Am Coll Cardiol. 1993;22:291-295.
36. Mahoney CW, Azzi A. Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun. 1988;154:694-697.
37. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest. 1991;87:1643-1648.
38. Kugiyama K, Ohgushi M, Sugiyama S, Murohara T, Fukunaga K, Miyamoto E, Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992;71:1422-1428
39. Matsuda Y, Hirata K, Inoue N, Suematsu M, Kawashima S, Akita H, Yokoyama M. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res. 1993;72:1103-1109.